Professor Marcus Maurer is joined by Dr Emek Kocatürk Göncü who addresses concerns regarding the impact of COVID-19 infection in patients with chronic urticaria and summarises the results of the recent UCARE project, PREG-CU.
For many years, antihistamines have been a cornerstone of chronic urticaria therapy, but is there room for improvement? In this episode, Professor Martin Church reflects on the enormous progress that has been made in the field of urticariology over the course of his career and discusses what is yet to come for patients with this devastating disease.
Professor Marcus Maurer is joined by “UCARE father”, Dr Luis Felipe Ensina, to discuss the frequently underestimated burden of urticaria, which Dr Ensina explains is not limited to the patients themselves, but may indirectly impact numerous friends and family members as well.
With the sixth consensus meeting on the international EAACI/GA²LEN/EuroGuiDerm guideline for urticaria fast approaching, Professor Marcus Maurer is joined by guideline development group member, Professor Torsten Zuberbier, who explains what we can expect from this new edition.
Patients with chronic conditions are increasingly seeking information from information and communications technologies (ICTs) to manage their health. As of yet, it is not known which general or specific ICTs patients use to obtain information on health-related topics and specifically on CU, or how patients perceive the currently available information via ICTs. Gaining knowledge on this is...